EAST PROVIDENCE, R.I. (WPRI) — The popularity of GLP-1 drugs has grown exponentially in recent years.
They’re largely touted for their weight loss benefits, but the drug can also significantly reduce cardiovascular events in high-risk patients.
A study last month in BMJ Medicine, however, found that the cardiovascular benefit could essentially be reversed when a patient goes off the drug …